Dr. Jennifer McVean, MD, is a nationally recognized pediatric endocrinologist and diabetes specialist dedicated to improving the lives of children and families affected by diabetes and endocrine disorders. Diagnosed with Type 1 diabetes at age 11, Dr. McVean brings a unique perspective to patient care by combining her personal experience with extensive medical expertise.
She earned her medical degree from the University of Minnesota Medical School, completed her pediatric residency at the University of Colorado, and a fellowship in Pediatric Endocrinology and Diabetes at the University of Wisconsin. Board-certified in Pediatrics and Pediatric Endocrinology, Dr. McVean has held leadership, academic, and clinical positions with esteemed healthcare organizations, including the University of Minnesota, Children’s Minnesota, Gundersen Health System, Hudson Physicians, and Medtronic Diabetes.
At Hudson Physicians, Dr. McVean specializes in pediatric endocrinology, focusing exclusively on hormone and metabolic conditions affecting children and adolescents. Her areas of expertise include:
- Type 1 and Type 2 diabetes
- Early or delayed puberty
- Growth concerns and short stature
- Thyroid disorders in children
- Pediatric obesity and metabolic conditions
- Adrenal and pituitary disorders
- Polycystic Ovary Syndrome in adolescents
Dr. McVean has a special interest in Type 1 diabetes awareness and early identification. Research indicates that relatives of individuals with Type 1 diabetes are significantly more likely to develop the condition than the general population. Studies also demonstrate that when children are monitored through early detection programs, the risk of diabetic ketoacidosis (DKA) at diagnosis drops from approximately 30 percent to 3 percent. DKA is a serious and potentially life-threatening complication of Type 1 diabetes. Early awareness and education can make a meaningful difference in outcomes.
In addition to her clinical practice, Dr. McVean serves as Senior Director of Medical Affairs for Medtronic Diabetes. In this role, she provides medical expertise and strategic guidance on regulatory strategy, evidence development, product design, clinical communications and publications, marketing and commercial strategies, and training and support needs. Her work has contributed to advancements in automated insulin delivery systems, diabetes technology adoption, and improved outcomes for pediatric patients worldwide.
Dr. McVean has been actively involved with numerous diabetes advocacy and educational organizations, including the Juvenile Diabetes Research Foundation (JDRF), American Diabetes Association (ADA), ADA Camp Needlepoint, TrialNet Research Network, and the Pediatric Endocrine Society. She has dedicated years to mentoring, research, education, and community outreach focused on improving diabetes awareness, prevention, and treatment.
Through her clinical leadership, research contributions, and work in medical technology, Dr. Jennifer McVean continues to influence the future of diabetes care worldwide. Her mission remains focused on helping individuals with diabetes achieve healthier, more independent lives while advancing innovations that reduce the burden of disease for future generations.
Dr. Jennifer McVean has become a respected voice in the Type 1 Diabetes community through her leadership, advocacy, and commitment to advancing diabetes care. Living with Type 1 Diabetes herself, Dr. McVean brings both personal experience and medical expertise to the search for better treatments and, ultimately, a cure.
Her work has helped accelerate awareness of emerging disease-modifying therapies, early detection programs, advanced insulin delivery systems, and next-generation cell-based treatments that are changing the future of Type 1 Diabetes care. Researchers worldwide are now making significant progress toward therapies that may delay, prevent, or one day eliminate the need for lifelong insulin dependence.
As a physician, educator, and advocate, Dr. McVean continues to support groundbreaking research efforts aimed at preserving insulin-producing cells, improving quality of life, and moving the medical community closer to a world without Type 1 Diabetes. While no definitive cure has yet been approved, the pace of innovation has never been greater, and leaders like Dr. McVean are helping drive that progress forward.
To learn more about Dr. Jennifer McVean and her work, visit her profile at Hudson Physicians.